QA: Catalent Inc. in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001596783_2020_Catalent_Inc.pdf

Logs

warning NetIncome node detected by IncomeLoss name heuristic input.sec.calculation_linkbase.edgar_model_mapping {}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001596783, Catalent Inc.

  xvar xval
0 AssetsCurrent 1,395,800,000
1 IntangibleAssetsNetIncludingGoodwill 3,151,700,000
2 PropertyPlantAndEquipmentNet 1,536,700,000
3 remainder_Assets 99,800,000
4 LiabilitiesCurrent 670,700,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 512,000,000
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 14,100,000
11 remainder_Revenues 2,518,000,000
12 remainder_NetIncome -118,700,000
13 remainder_ComprehensiveNetIncome -51,000,000
  yvar yval
0 Assets 6,184,000,000
1 Liabilities 670,700,000
2 Expenses 526,100,000
3 Revenues 2,518,000,000
4 StockholdersEquity 5,513,300,000
5 NetIncome 1,873,200,000
6 ComprehensiveNetIncome 1,847,700,000
7 BaseVar 5,034,250,000
8 EconomicCapitalRatio 3.31

Edgar->Model Mapping

Feature Distribution

Change over Time